Logo image of TVGN

TEVOGEN BIO HOLDINGS INC (TVGN) Stock Price, Forecast & Analysis

USA - NASDAQ:TVGN - US88165K1016 - Common Stock

0.6005 USD
-0.02 (-2.5%)
Last: 10/30/2025, 8:00:01 PM
0.6005 USD
0 (0%)
Pre-Market: 10/31/2025, 9:06:00 AM

TVGN Key Statistics, Chart & Performance

Key Statistics
Market Cap118.12M
Revenue(TTM)N/A
Net Income(TTM)57.54M
Shares196.71M
Float40.60M
52 Week High2.36
52 Week Low0.58
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.38
PE1.58
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO2021-11-04
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


TVGN short term performance overview.The bars show the price performance of TVGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

TVGN long term performance overview.The bars show the price performance of TVGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TVGN is 0.6005 USD. In the past month the price decreased by -22.95%. In the past year, price decreased by -74.66%.

TEVOGEN BIO HOLDINGS INC / TVGN Daily stock chart

TVGN Latest News, Press Relases and Analysis

TVGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.55 403.13B
AMGN AMGEN INC 13.39 157.20B
GILD GILEAD SCIENCES INC 14.46 146.96B
VRTX VERTEX PHARMACEUTICALS INC 24.79 107.66B
REGN REGENERON PHARMACEUTICALS 14.53 69.32B
ALNY ALNYLAM PHARMACEUTICALS INC 345.82 58.93B
ARGX ARGENX SE - ADR 61.91 50.51B
INSM INSMED INC N/A 41.05B
ONC BEONE MEDICINES LTD-ADR 4.97 33.85B
NTRA NATERA INC N/A 26.52B
BNTX BIONTECH SE-ADR N/A 25.16B
BIIB BIOGEN INC 8.94 21.93B

About TVGN

Company Profile

TVGN logo image Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company is headquartered in Warren, New Jersey and currently employs 18 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.

Company Info

TEVOGEN BIO HOLDINGS INC

15 Independence Boulevard, Suite #210

WARREN NEW JERSEY US

Employees: 18

TVGN Company Website

Phone: 16468078832

TEVOGEN BIO HOLDINGS INC / TVGN FAQ

What does TVGN do?

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company is headquartered in Warren, New Jersey and currently employs 18 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.


What is the current price of TVGN stock?

The current stock price of TVGN is 0.6005 USD. The price decreased by -2.5% in the last trading session.


Does TEVOGEN BIO HOLDINGS INC pay dividends?

TVGN does not pay a dividend.


How is the ChartMill rating for TEVOGEN BIO HOLDINGS INC?

TVGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What sector and industry does TEVOGEN BIO HOLDINGS INC belong to?

TEVOGEN BIO HOLDINGS INC (TVGN) operates in the Health Care sector and the Biotechnology industry.


Can you provide the upcoming earnings date for TEVOGEN BIO HOLDINGS INC?

TEVOGEN BIO HOLDINGS INC (TVGN) will report earnings on 2025-11-10.


TVGN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TVGN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TVGN. TVGN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TVGN Financial Highlights

Over the last trailing twelve months TVGN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 375% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 337.72%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%640%
Sales Q2Q%N/A
EPS 1Y (TTM)375%
Revenue 1Y (TTM)N/A

TVGN Forecast & Estimates

7 analysts have analysed TVGN and the average price target is 10.2 USD. This implies a price increase of 1598.58% is expected in the next year compared to the current price of 0.6005.


Analysts
Analysts82.86
Price Target10.2 (1598.58%)
EPS Next YN/A
Revenue Next YearN/A

TVGN Ownership

Ownership
Inst Owners2.57%
Ins Owners79.36%
Short Float %5.25%
Short Ratio4.19